[Use of illicit substances in the workplace]

Area of Science:

• Occupational Health
• Addiction Medicine
• Public Health

Background:

• Addictive behaviors are a significant concern for workplace and occupational physicians.
• Prevalence estimation relies on self-assessment or biological testing, with workplace policies influencing results.
• Limited data exists on substance use prevalence in French workplaces.

Purpose of the Study:

• To highlight the necessity of screening for illicit substances in the workplace.
• To address the lack of published workplace substance use data in France.
• To emphasize the role of knowledge in improving job security and prevention campaigns.

Main Methods:

• Review of existing data from organizations like the United Nations Office against Drugs and Crime (UNODC).
• Comparison of prevalence rates in the general population versus specific European workplace sectors.
• Discussion of challenges in French workplace substance use research, including anonymity concerns.

Main Results:

• General population substance use data for France (cannabis, cocaine, amphetamines, opiates) from 2005-2007.
• Reported prevalence in various European industrial and professional fields.
• Identified a scarcity of French workplace-specific investigations.

Conclusions:

• Screening for illicit psychotropic substances is vital due to risks to alertness and job security.
• Reliable, inexpensive screening methods are needed for routine workplace assessment.
• Disseminating results can drive more effective workplace information and prevention campaigns.